Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

PacificHealth Laboratories Inc

PHLI
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US6951131001
Sector Consumer Defensive
Industry Household & Personal Products
Exchange PINK
Capitalization 438 307 USD
Yield for 12 month
1Y
3Y
5Y
10Y
15Y
PHLI
21.11.2021 - 28.11.2021

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey. Address: 100 Matawan Road, Matawan, NJ, United States, 07747

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.8 USD

P/E ratio

Dividend Yield

Current Year

+6 914 818 USD

Last Year

+7 200 960 USD

Current Quarter

+1 721 119 USD

Last Quarter

+2 229 234 USD

Current Year

+2 987 523 USD

Last Year

+3 163 628 USD

Current Quarter

+585 103 USD

Last Quarter

+866 105 USD

Key Figures PHLI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -861 233 USD
Operating Margin TTM -19.63 %
PE Ratio
Return On Assets TTM -24.6 %
PEG Ratio
Return On Equity TTM -74.61 %
Wall Street Target Price 2.8 USD
Revenue TTM 6 667 649 USD
Book Value 0.04 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -12.7 %
Dividend Yield
Gross Profit TTM 2 987 523 USD
Earnings per share
Diluted Eps TTM
Most Recent Quarter III 2012
Quarterly Earnings Growth YOY
Profit Margin -14.15 %

Dividend Analytics PHLI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PHLI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation PHLI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.0858
Price Sales TTM 0.0657
Enterprise Value EBITDA -0.6644
Price Book MRQ 0.7066

Financials PHLI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PHLI

For 52 weeks

0.0001 USD 0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 1 350
200 Day MA 0.0001 USD
Short Ratio 0.28
Shares Short
Short Percent